CARA INNUS: Open Payments
NPI 1538126388 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 16 payments from 5 companies in 2025. Trend: 2023 $17 · 2024 $0 · 2025 $528
Food & beverage: $528
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $147 |
| Janssen Biotech, Inc. | 8 | $137 |
| Genentech USA, Inc. | 1 | $126 |
| PFIZER INC. | 5 | $97 |
| QOL Medical, LLC | 1 | $20 |
Products named: REZDIFFRA, TREMFYA, Xolair, VELSIPITY, Sucraid, XELJANZ.
Industry payments across NY — which companies pay providers there.
